Novelix Pharmaceuticals jumps on entering into agreement with GMBU e.V., Halle
Novelix Pharmaceuticals is currently trading at Rs. 59.00, up by 4.64 points or 8.54% from its previous closing of Rs. 54.36 on the BSE.
The scrip opened at Rs. 57.00 and has touched a high and low of Rs. 60.00 and Rs. 56.30 respectively. So far 18527 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 70.16 on 19-Nov-2025 and a 52 week low of Rs. 29.33 on 9-Jun-2025.
Last one week high and low of the scrip stood at Rs. 60.00 and Rs. 50.60 respectively. The current market cap of the company is Rs. 140.98 crore.
The promoters holding in the company stood at 49.43%, while Non-Institutions held 50.57% stake in the company.
Novelix Pharmaceuticals has entered into an agreement with GMBU e.V., Halle (Saale), Germany for the production scale up of Astaxanthin at commercial level at the company’s research facilities in Hyderabad, India after the success of pilot scale production.
